{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:45Z","timestamp":1790916825500,"version":"4.1.0"},"reference-count":87,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:00:00Z","timestamp":1717027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>With advances in technology and medicine over the last 3 decades, cardiovascular medicine has evolved tremendously. Nanotechnology provides a promising future in personalized precision medicine. In this review, we delve into the current and prospective applications of nanotechnology and nanoparticles in cardiology. Nanotechnology has allowed for point-of-care testing such as high-sensitivity troponins, as well as more precise cardiac imaging. This review is focused on 3 diseases within cardiology: coronary artery disease, heart failure, and valvular heart disease. The use of nanoparticles in coronary stents has shown success in preventing in-stent thrombosis, as well as using nanosized drug delivery medications to prevent neointimal proliferation in a way that spares systemic toxicity. In addition, by using nanoparticles as drug delivery systems, nanotechnology can be utilized in the delivery of goal-directed medical therapy in heart failure patients. It has also been shown to improve cell therapy in this patient population by helping in cell retention of grafts. Finally, the use of nanoparticles in the manufacturing of bioprosthetic valves provides a promising future for the longevity and success of cardiac valve repair and replacement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/crd.0000000000000727","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T09:08:36Z","timestamp":1717060116000},"page":"515-522","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Nanotechnology: The Future for Diagnostic and Therapeutic Intervention in Cardiovascular Diseases is Here"],"prefix":"10.1097","volume":"34","author":[{"given":"Jude","family":"Elsaygh","sequence":"first","affiliation":[{"name":"Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Zaher","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish A.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY"},{"name":"Weill Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY"},{"name":"Weill Department of Medicine, Weill Cornell Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"R1-20261002","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/nn900002m","article-title":"Impact of nanotechnology on drug delivery.","volume":"3","author":"Farokhzad","year":"2009","journal-title":"ACS Nano"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1520\/JAI13110","article-title":"Nanotechnology\u2014an introduction for the standards community.","volume":"2","author":"Mansoori","year":"2005","journal-title":"J ASTM Int"},{"key":"R4-20261002","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1039\/C4CS00177J","article-title":"Upconverting nanoparticles: assessing the toxicity.","volume":"44","author":"Gnach","year":"2015","journal-title":"Chem Soc Rev"},{"key":"R5-20261002","first-page":"22","article-title":"There\u2019s plenty of room at the bottom.","volume":"23","author":"Feynman","year":"1960","journal-title":"Eng Sci"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0963662509347815","article-title":"From enabling technology to applications: the evolution of risk perceptions about nanotechnology.","volume":"20","author":"Cacciatore","year":"2011","journal-title":"Public Understand Sci"},{"key":"R8-20261002","doi-asserted-by":"crossref","first-page":"w14044","DOI":"10.4414\/smw.2014.14044","article-title":"Nanotechnology in medicine: European research and its implications.","volume":"144","author":"Hofmann-Amtenbrink","year":"2014","journal-title":"Swiss Med Wkly"},{"key":"R9-20261002","first-page":"78","article-title":"An introduction to nanotechnology and its implications.","volume":"5","author":"Subedi","year":"2014","journal-title":"Him Phy"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.3390\/ijms23052658","article-title":"Molecular imaging and nanotechnology-emerging tools in diagnostics and therapy.","volume":"23","author":"Wo\u017aniak","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study.","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s44161-023-00232-y","article-title":"Nanomedicines for cardiovascular disease.","volume":"2","author":"Smith","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCRESAHA.119.314937","article-title":"Comparative analysis of circulating noncoding RNAs versus protein biomarkers in the detection of myocardial injury.","volume":"125","author":"Schulte","year":"2019","journal-title":"Circ Res"},{"key":"R15-20261002","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-anchem-061318-115027","article-title":"Development and applications of bioluminescent and chemiluminescent reporters and biosensors.","volume":"12","author":"Yeh","year":"2019","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"25899","DOI":"10.1021\/acsomega.0c03260","article-title":"Electroanalysis on an interdigitated electrode for high-affinity cardiac troponin I biomarker detection by aptamer-gold conjugates.","volume":"5","author":"Zhang","year":"2020","journal-title":"ACS Omega"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3389\/fbioe.2020.00531","article-title":"Nanoscale technologies in highly sensitive diagnosis of cardiovascular diseases.","volume":"8","author":"Shi","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1039\/C8AY02617C","article-title":"Label free electrochemical detection of cardiac biomarker troponin T using ZnSnO3 perovskite nanomaterials.","volume":"11","author":"Supraja","year":"2019","journal-title":"Anal Methods"},{"key":"R19-20261002","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1039\/C7AN00430C","article-title":"Achieving biosensing at attomolar concentrations of cardiac troponin T in human biofluids by developing a label-free nanoplasmonic analytical assay.","volume":"142","author":"Liyanage","year":"2017","journal-title":"Analyst"},{"key":"R20-20261002","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1021\/acs.analchem.8b04640","article-title":"Dual-wavelength ratiometric electrochemiluminescence immunosensor for cardiac troponin I Detection.","volume":"91","author":"Ye","year":"2019","journal-title":"Anal Chem"},{"key":"R21-20261002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bios.2018.12.049","article-title":"Paper microfluidic device for early diagnosis and prognosis of acute myocardial infarction via quantitative multiplex cardiac biomarker detection.","volume":"128","author":"Lim","year":"2019","journal-title":"Biosens Bioelectron"},{"key":"R22-20261002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.snb.2018.11.074","article-title":"Point of care upconversion nanoparticles-based lateral flow assay quantifying myoglobin in clinical human blood samples.","volume":"282","author":"Ji","year":"2019","journal-title":"Sensor Actuator B Chem"},{"key":"R23-20261002","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1021\/acs.analchem.9b03001","article-title":"Target-induced payload amplification for spherical nucleic acid enzyme (SNAzyme)-catalyzed electrochemiluminescence detection of circulating microRNAs.","volume":"91","author":"Sun","year":"2019","journal-title":"Anal Chem"},{"key":"R24-20261002","first-page":"26","article-title":"PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.","volume":"53","author":"Laufer","year":"2009","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R25-20261002","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.051052","article-title":"Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis.","volume":"125","author":"Dweck","year":"2012","journal-title":"Circulation"},{"key":"R26-20261002","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1161\/CIRCULATIONAHA.107.732867","article-title":"Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo.","volume":"116","author":"Aikawa","year":"2007","journal-title":"Circulation"},{"key":"R27-20261002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pacs.2015.08.004","article-title":"Sensing the delivery and endocytosis of nanoparticles using magneto-photo-acoustic imaging.","volume":"3","author":"Qu","year":"2015","journal-title":"Photoacoustics"},{"key":"R28-20261002","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.biomaterials.2017.04.037","article-title":"Molecular imaging of activated platelets via antibody-targeted ultrasmall iron oxide nanoparticles displaying unique dual MRI contrast.","volume":"134","author":"Ta","year":"2017","journal-title":"Biomaterials"},{"key":"R29-20261002","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1039\/C9TB01834D","article-title":"Cyclic RGD functionalized liposomes targeted to activated platelets for thrombosis dual-mode magnetic resonance imaging.","volume":"8","author":"Ye","year":"2020","journal-title":"J Mater Chem B"},{"key":"R30-20261002","doi-asserted-by":"crossref","first-page":"14789","DOI":"10.1021\/jacs.0c07022","article-title":"Advanced fluorescence imaging technology in the near-infrared-II window for biomedical applications.","volume":"142","author":"Li","year":"2020","journal-title":"J Am Chem Soc"},{"key":"R31-20261002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nano.2018.12.015","article-title":"Unambiguous detection of atherosclerosis using bioorthogonal nanomaterials.","volume":"17","author":"Pellico","year":"2019","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"R32-20261002","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins.","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R33-20261002","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/S0140-6736(07)60716-8","article-title":"The safety of statins in clinical practice.","volume":"370","author":"Armitage","year":"2007","journal-title":"Lancet"},{"key":"R34-20261002","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1039\/D0NR00308E","article-title":"Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles.","volume":"12","author":"Hossaini Nasr","year":"2020","journal-title":"Nanoscale"},{"key":"R35-20261002","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"key":"R36-20261002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41551-018-0221-2","article-title":"Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.","volume":"2","author":"Lameijer","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"R37-20261002","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jacc.2017.11.055","article-title":"Targeting CD40-Induced TRAF6 signaling in macrophages reduces atherosclerosis.","volume":"71","author":"Seijkens","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R38-20261002","doi-asserted-by":"crossref","first-page":"E6731","DOI":"10.1073\/pnas.1609629113","article-title":"Immune cell screening of a nanoparticle library improves atherosclerosis therapy.","volume":"113","author":"Tang","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"R39-20261002","doi-asserted-by":"crossref","first-page":"1700313","DOI":"10.1002\/adhm.201700313","article-title":"Targeted nanotherapeutics encapsulating liver X receptor agonist GW3965 enhance antiatherogenic effects without adverse effects on hepatic lipid metabolism in Ldlr(-\/-) mice.","volume":"6","author":"Yu","year":"2017","journal-title":"Adv Healthc Mater"},{"key":"R40-20261002","first-page":"399","article-title":"Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.","volume":"60","author":"Wieneke","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"key":"R41-20261002","first-page":"85","article-title":"Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.","volume":"64","author":"Kollum","year":"2005","journal-title":"Catheter Cardiovasc Interv"},{"key":"R42-20261002","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/01.CIR.0000023532.98469.48","article-title":"Macrophage depletion by clodronate-containing liposomes reduces neointimal formation after balloon injury in rats and rabbits.","volume":"106","author":"Danenberg","year":"2002","journal-title":"Circulation"},{"key":"R43-20261002","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1161\/01.CIR.0000097002.69209.CD","article-title":"Liposomal alendronate inhibits systemic innate immunity and reduces in-stent neointimal hyperplasia in rabbits.","volume":"108","author":"Danenberg","year":"2003","journal-title":"Circulation"},{"key":"R44-20261002","first-page":"143","article-title":"Nanoparticulate carriers for the treatment of coronary restenosis.","volume":"2","author":"Brito","year":"2007","journal-title":"Int J Nanomedicine"},{"key":"R45-20261002","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/ATVBAHA.108.170662","article-title":"Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.","volume":"28","author":"Joner","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R46-20261002","doi-asserted-by":"crossref","first-page":"8346","DOI":"10.1073\/pnas.0909506107","article-title":"Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields.","volume":"107","author":"Chorny","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"R47-20261002","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.biomaterials.2009.10.051","article-title":"A nitric oxide releasing, self assembled peptide amphiphile matrix that mimics native endothelium for coating implantable cardiovascular devices.","volume":"31","author":"Kushwaha","year":"2010","journal-title":"Biomaterials"},{"key":"R48-20261002","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1016\/j.biomaterials.2011.08.018","article-title":"Selective adhesion and growth of vascular endothelial cells on bioactive peptide nanofiber functionalized stainless steel surface.","volume":"32","author":"Ceylan","year":"2011","journal-title":"Biomaterials"},{"key":"R49-20261002","first-page":"5","article-title":"Drug delivery and targeting.","volume":"392","author":"Langer","year":"1998","journal-title":"Nature"},{"key":"R50-20261002","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1021\/nl2025882","article-title":"Nanoparticles targeting the infarcted heart.","volume":"11","author":"Dvir","year":"2011","journal-title":"Nano Lett"},{"key":"R51-20261002","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1002\/adma.201502003","article-title":"Enzyme-responsive nanoparticles for targeted accumulation and prolonged retention in heart tissue after myocardial infarction.","volume":"27","author":"Nguyen","year":"2015","journal-title":"Adv Mater"},{"key":"R52-20261002","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12265-011-9292-0","article-title":"N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing.","volume":"4","author":"Gray","year":"2011","journal-title":"J Cardiovasc Transl Res"},{"key":"R53-20261002","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/hh1101.091193","article-title":"Arrhythmogenesis and contractile dysfunction in heart failure.","volume":"88","author":"Pogwizd","year":"2001","journal-title":"Circ Res"},{"key":"R54-20261002","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.RES.85.1.38","article-title":"Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium.","volume":"85","author":"Pieske","year":"1999","journal-title":"Circ Res"},{"key":"R55-20261002","doi-asserted-by":"crossref","first-page":"13889","DOI":"10.1073\/pnas.241393598","article-title":"S100A1: a regulator of myocardial contractility.","volume":"98","author":"Most","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"R56-20261002","doi-asserted-by":"crossref","first-page":"33809","DOI":"10.1074\/jbc.M301788200","article-title":"Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance.","volume":"278","author":"Most","year":"2003","journal-title":"J Biol Chem"},{"key":"R57-20261002","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1172\/JCI21454","article-title":"Cardiac adenoviral S100A1 gene delivery rescues failing myocardium.","volume":"114","author":"Most","year":"2004","journal-title":"J Clin Invest"},{"key":"R58-20261002","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.2217\/nnm.15.126","article-title":"Bioactive nanoparticles improve calcium handling in failing cardiac myocytes.","volume":"10","author":"Maxwell","year":"2015","journal-title":"Nanomedicine (Lond)"},{"key":"R59-20261002","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.RES.83.5.516","article-title":"Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I.","volume":"83","author":"Wang","year":"1998","journal-title":"Circ Res"},{"key":"R60-20261002","doi-asserted-by":"crossref","first-page":"8630","DOI":"10.1073\/pnas.93.16.8630","article-title":"Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice.","volume":"93","author":"Reiss","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"R61-20261002","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2013.04.022","article-title":"Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.","volume":"170","author":"Chang","year":"2013","journal-title":"J Control Release"},{"key":"R62-20261002","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1172\/JCI117706","article-title":"Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure.","volume":"95","author":"Duerr","year":"1995","journal-title":"J Clin Invest"},{"key":"R63-20261002","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00005082-200207000-00003","article-title":"Coenzyme Q10 and cardiovascular disease: a review.","volume":"16","author":"Sarter","year":"2002","journal-title":"J Cardiovasc Nurs"},{"key":"R64-20261002","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(99)04180-X","article-title":"Cardiovascular gene therapy.","volume":"355","author":"Yla-Herttuala","year":"2000","journal-title":"Lancet"},{"key":"R65-20261002","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy.","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat Rev Genet"},{"key":"R66-20261002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1073\/pnas.0803746106","article-title":"Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles.","volume":"106","author":"Hofmann","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"R67-20261002","doi-asserted-by":"crossref","first-page":"13801","DOI":"10.1073\/pnas.250488097","article-title":"Adeno-associated viral vector- mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.","volume":"97","author":"Su","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"R68-20261002","doi-asserted-by":"crossref","first-page":"130ra147","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.","volume":"4","author":"Sun","year":"2012","journal-title":"Sci Transl Med"},{"key":"R69-20261002","first-page":"CD007888","article-title":"Stem cell therapy for chronic ischaemic heart disease and congestive heart failure.","volume":"4","author":"Fisher","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R70-20261002","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jtcvs.2006.05.034","article-title":"Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty.","volume":"132","author":"Teng","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R71-20261002","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2009.04.097","article-title":"Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.","volume":"54","author":"Terrovitis","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R72-20261002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biomaterials.2017.11.012","article-title":"Improved heart repair upon myocardial infarction: combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytes.","volume":"155","author":"Ottersbach","year":"2018","journal-title":"Biomaterials"},{"key":"R73-20261002","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1038\/ncomms5880","article-title":"Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting.","volume":"5","author":"Cheng","year":"2014","journal-title":"Nat Commun"},{"key":"R74-20261002","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1126\/science.1175202","article-title":"Identification of splenic reservoir monocytes and their deployment to inflammatory sites.","volume":"325","author":"Swirski","year":"2009","journal-title":"Science"},{"key":"R75-20261002","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nbt874","article-title":"Fabrication of novel biomaterials through molecular self-assembly.","volume":"21","author":"Zhang","year":"2003","journal-title":"Nat Biotechnol"},{"key":"R76-20261002","doi-asserted-by":"crossref","first-page":"033504","DOI":"10.1088\/1468-6996\/16\/3\/033504","article-title":"Tangible nanocomposites with diverse properties for heart valve application.","volume":"16","author":"Vellayappan","year":"2015","journal-title":"Sci Technol Adv Mater"},{"key":"R77-20261002","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/ar050055b","article-title":"Polyhedral oligomeric silsesquioxane nanocomposites: the next generation material for biomedical applications.","volume":"38","author":"Kannan","year":"2005","journal-title":"Acc Chem Res"},{"key":"R78-20261002","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0142-9612(95)00242-1","article-title":"New polyurethane heart valve prosthesis: design, manufacture and evaluation.","volume":"17","author":"Mackay","year":"1996","journal-title":"Biomaterials"},{"key":"R79-20261002","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1097-4636(199723)38:3<263::AID-JBM11>3.0.CO;2-C","article-title":"Directions for improvement of substitute heart valves: national heart, lung, and blood institute\u2019s working group report on heart valves.","volume":"38","author":"Edmunds","year":"1997","journal-title":"J Biomed Mater Res"},{"key":"R80-20261002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nano.2013.06.006","article-title":"Design and development of nanocomposite scaffolds for auricular reconstruction.","volume":"10","author":"Nayyer","year":"2014","journal-title":"Nanomedicine"},{"key":"R81-20261002","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0140-6736(11)61715-7","article-title":"Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study.","volume":"378","author":"Jungebluth","year":"2011","journal-title":"Lancet"},{"key":"R82-20261002","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/bab.53","article-title":"Development of a new lacrimal drainage conduit using POSS nanocomposite.","volume":"58","author":"Chaloupka","year":"2011","journal-title":"Biotechnol Appl Biochem"},{"key":"R83-20261002","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.biotechadv.2012.12.010","article-title":"Evolution of covered stents in the contemporary era: clinical application, materials and manufacturing strategies using nanotechnology.","volume":"31","author":"Farhatnia","year":"2013","journal-title":"Biotechnol Adv"},{"key":"R84-20261002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/A:1004775229149","article-title":"Bacterial cellulose\u2014a masterpiece of nature\u2019s arts.","volume":"35","author":"Iguchi","year":"2000","journal-title":"J Mater Sci"},{"key":"R85-20261002","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0079-6700(01)00021-1","article-title":"Bacterial synthesized cellulose\u2014artificial blood vessels for microsurgery.","volume":"26","author":"Klemm","year":"2001","journal-title":"Prog Polym Sci"},{"key":"R86-20261002","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/bk-2006-0938.ch015","article-title":"Bacterial cellulose and its nanocomposites for biomedical applications cellulose nanocomposites.","volume":"938","author":"Wan","year":"2006","journal-title":"ACS Symp Ser"},{"key":"R87-20261002","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.athoracsur.2004.06.033","article-title":"Calcification of tissue heart valve substitutes: progress toward understanding and prevention.","volume":"79","author":"Schoen","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"R88-20261002","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1615\/JLongTermEffMedImplants.v11.i34.30","article-title":"The failure modes of biological prosthetic heart valves.","volume":"11","author":"Butany","year":"2001","journal-title":"J Long Term Eff Med Implants"},{"key":"R89-20261002","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1517\/14712590903085091","article-title":"Physiological variables involved in heart valve substitute calcification.","volume":"9","author":"Lee","year":"2009","journal-title":"Expert Opin Biol Ther"},{"key":"R90-20261002","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/j.actbio.2010.06.015","article-title":"The anti-calcification potential of a silsesquioxane nanocomposite polymer under in vitro conditions: potential material for synthetic leaflet heart valve.","volume":"6","author":"Ghanbari","year":"2010","journal-title":"Acta Biomater"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:01:01Z","timestamp":1790913661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CRD.0000000000000727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000727","relation":{},"ISSN":["1061-5377","1538-4683"],"issn-type":[{"value":"1061-5377","type":"print"},{"value":"1538-4683","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}